4.7 Review

Role of mTOR in Glucose and Lipid Metabolism

期刊

出版社

MDPI
DOI: 10.3390/ijms19072043

关键词

mTOR; metabolic diseases; glucose and lipid metabolism

资金

  1. National Natural Science Foundation of China [81500619, 81730020]
  2. National Key R&D Program of China [2017YFC0908900]
  3. Natural Science Foundation of Guangdong Province [2016A030310040]
  4. Shenzhen Science and Technology Project [JCYJ20160422091658982, JCYJ20150324140036854]
  5. Shenzhen Peacocok Plan [KQTD20140630100746562, 827-000107]
  6. Natural Science Foundation of SZU [201567]

向作者/读者索取更多资源

The mammalian target of rapamycin, mTOR is the master regulator of a cell's growth and metabolic state in response to nutrients, growth factors and many extracellular cues. Its dysregulation leads to a number of metabolic pathological conditions, including obesity and type 2 diabetes. Here, we review recent findings on the role of mTOR in major metabolic organs, such as adipose tissues, liver, muscle, pancreas and brain. And their potentials as the mTOR related pharmacological targets will be also discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据